IDR.com on MSN

China Won’t Be Sending Humans to the Moon, but Two Fully Robotized Dogs Named Anteater and Salamander

These machines may unlock a new chapter in lunar colonization, navigating where humans can’t and uncovering secrets buried ...
The Cool Down on MSN

Residents of US town near nuclear facility face alarming crisis: 'So many people are suffering'

"Our community shouldn’t be put at an increased risk." Residents of US town near nuclear facility face alarming crisis: 'So ...
Earth.com

Study reports these debilitating diseases are linked to geography, upending CDC research

Scientists found ALS and MS share a strong geographic pattern, suggesting common environmental causes behind both.
Morning Overview on MSN

NASA to build glass moon pods that look straight out of sci-fi

NASA is advancing ambitious plans to deploy massive glass pods on the Moon, designed to serve as habitats that evoke the ...

What Are Exosomes, The Lastest Skincare Ingredient Exciting Dermatologists?

They may cause temporary side effects: Some studies have found that using exosomes can cause temporary symptoms such as ...

DATROWAY® (datopotamab deruxtecan-dlnk) demonstrated unprecedented median overall survival improvement of five months vs. chemo as 1st-line treatment for patients with ...

Detailed price information for Astrazeneca Plc ADR (AZN-Q) from The Globe and Mail including charting and trades.
Le Lézard

Subcutaneous amivantamab delivers promising 45 percent overall response rate with median duration of 7.2 months in recurrent or metastatic head and neck cancer

Johnson & Johnson today announced promising new results from the Phase 1b/2 OrigAMI-4 study evaluating the efficacy and safety of subcutaneous (SC) amivantamab monotherapy in patients with human ...